1. Pink Sheet

GMP Inspectors Will Scrutinize Adverse Event Reporting Compliance

 
• By Elizabeth Crawford

Regular under-reporting of serious adverse event reports has spurred FDA to have its good manufacturing practice inspectors review dietary supplement firms’ AERs and reporting practices, FDA’s Fabricant says. Key compliance issues can tip off the agency that a company may be falling short on reporting.

With under-reporting of serious adverse events rampant, FDA’s good manufacturing practices inspections will look closer at dietary supplement firms’ compliance with AER regulations, said Division of Dietary Supplement Programs Director Dan Fabricant.

The agency, in turn, likely will increase enforcement actions

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Manufacturing

More from Compliance